Published: 21 March 2023
Author(s): Gian Luca Erre, Elena Bartoloni, Ombretta Viapiana, Elisa Gremese, Fabiola Atzeni, “Cardiovascular, Obesity and Rheumatic Disease Study (CORDIS) Group” of the Italian Society of Rheumatology (SIR)
Issue: May 2023
Section: Letter to the Editor

We appreciate the interest of Noriaki Kou and colleagues [1] in our article [2], and we fully agree that beside disease activity, therapies, and systemic inflammation other non-traditional cardiovascular risk factors such as extra-articular manifestations and positivity for anti-citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF) would negatively impact on the risk of future cardiovascular events in the RA population.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.